Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new window
info@pharmaust.com+61 8 9202 6814
PharmAust (PAA)
PharmAust (PAA)
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT

Author Archives: PharmAust

Appendix 4E Preliminary Final Report

Financial Reports 2019, News & Announcements 2019By PharmAustAugust 30, 2019

190830_Preliminary Final Report

Appendix 3B and s708 Notice

Financial Reports 2019, News & Announcements 2019By PharmAustAugust 28, 2019

190828_Appendix 3B & s708 notice

Arrival of GMP Tablets for Phase II Dog Trials

News & Announcements 2019By PharmAustAugust 26, 2019

190826_GMP Tablets Arrive_447v3rv314vgd9

Change of Director’s Interest Notice

News & Announcements 2019By PharmAustAugust 16, 2019

190816_Change of Director's Interest Notice 447k299n9rnrts

31 July 2019 Top 20 Shareholders

News & Announcements 2019, Top 20 ShareholdersBy PharmAustJuly 31, 2019

190731_Top_Holders_Report (33)

Appendix 4C and Quarterly Update

Financial Reports 2019, News & Announcements 2019By PharmAustJuly 30, 2019

4471277nx3858c

Appendix 3B & s708 Notice

Financial Reports 2019, News & Announcements 2019By PharmAustJuly 26, 2019

190729_Unlisted Options Issuance

July 25 Investor Presentation

Investor Presentations 2019, News & Announcements 2019By PharmAustJuly 26, 2019

190725_PAA PRESENTATION 25 JULY 2019

Response to ASX Price and Volume Query

News & Announcements 2019By PharmAustJuly 23, 2019

Response to ASX Price and Volume Query

23 July 2019, Change in Substantial Holding

Financial Reports 2019, News & Announcements 2019By PharmAustJuly 23, 2019

Change in Substantial Holding

1
234567891011121314
…1516171819…
20212223242526272829303132333435363738394041424344
45
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER

TWITTER

PharmAust Follow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

PharmAust
Retweet on Twitter PharmAust Retweeted
pharmaust PharmAust @pharmaust ·
25 Jul

PharmAust is pleased to announce that leading Australian broking and corporate advisory firm, @JPEquityPartner, has updated their research coverage on $PAA
 
A full copy of the research note is available for download here 👉 https://www.pharmaust.com/jp-equity-research-report/

Reply on Twitter 1551424206805405699 Retweet on Twitter 1551424206805405699 3 Like on Twitter 1551424206805405699 13 Twitter 1551424206805405699
Load More
Copyright © 2020 Pharmaust. All rights reserved.
nil

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top